Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU)
| Assets | $3.86M |
| Expense Ratio | 0.97% |
| PE Ratio | n/a |
| Shares Out | 125,001 |
| Dividend (ttm) | $0.41 |
| Dividend Yield | 1.34% |
| Ex-Dividend Date | Dec 23, 2025 |
| Payout Frequency | Monthly |
| Payout Ratio | n/a |
| Volume | 4,080 |
| Open | 31.79 |
| Previous Close | 31.12 |
| Day's Range | 30.65 - 31.79 |
| 52-Week Low | 25.71 |
| 52-Week High | 38.89 |
| Beta | n/a |
| Holdings | 11 |
| Inception Date | Oct 1, 2025 |
About TBXU
Fund Home PageThe Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is an exchange-traded fund that mostly invests in health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry. TBXU was launched on Oct 1, 2025 and is issued by Direxion.
Top 10 Holdings
99.44% of assets| Name | Symbol | Weight |
|---|---|---|
| Goldman Finl Sq Trsry Inst 506 | n/a | 22.28% |
| Dreyfus Govt Cash Man Ins | n/a | 17.40% |
| Goldman Sachs Fin Gov 465 Institut | n/a | 11.33% |
| Regeneron Pharmaceuticals, Inc. | REGN | 9.50% |
| Amgen Inc. | AMGN | 9.30% |
| Vertex Pharmaceuticals Incorporated | VRTX | 9.27% |
| Gilead Sciences, Inc. | GILD | 8.94% |
| argenx SE | ARGX | 8.10% |
| Dx D Biotech T 5 Bull 2x Etf Swap | n/a | 2.00% |
| Dx D Biotech T 5 Bull 2x Etf Swap | n/a | 1.32% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2025 | $0.10111 | Dec 31, 2025 |
| Dec 10, 2025 | $0.31143 | Dec 17, 2025 |
Performance
News
Remember the Titans ETFs For Opportunities in 2026
In October 2025, Direxion Investments welcomed a new family of ETFs into their ever-growing roster of leveraged and inverse funds: the Titans ETFs. The suite of funds essentially give traders a middle...
New FDA Director Could Sway Biotech ETFs
Biotech stocks could sway toward the upside with the appointment of a new director at the Federal Drug Administration's Center for Drug Evaluation and Research. Dr. Richard Pazdur will take the reigns...
Trade the Titans: Direxion Debuts New Suite of Leveraged & Inverse ETFs
New York, United States, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Direxion, a leading provider of tactical ETFs, today announced the launch of the Direxion Titans Leveraged & Inverse ETFs, a new suite of fun...